aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, Hidenori Toyoda et al.|Journal of Hepatology|2020Cited by 346
Mefatinib as first-line treatment of patients with advanced non–small cell lung cancer harboring rare EGFR mutations.Pingli Wang, Kai Wang, Liming Cao et al.|Journal of Clinical Oncology|2022Cited by 0